Scientists have confirmed that viruses can kill marine algae called diatoms and that diatom die-offs near the ocean surface may provide nutrients and organic matter for recycling by other algae, according to a Rutgers-led study.
A new review article appearing in the journal Nature Reviews Microbiology highlights the evolution and ecology of plant viruses. Arvind Varsani, a researcher at ASU's Biodesign Institute joins an international team to explore many details of viral dynamics. They describe the subtle interplay between three components of the viral infection process, the virus itself, the plant cell hosts infected by the virus and the vectors that act as go-betweens -- an intricate system evolving over some 450 million years.
London's house sparrows (Passer domesticus) have plummeted by 71% since 1995, with new research suggesting avian malaria could be to blame.
Gut microbes produce compounds that prime immune cells to destroy harmful viruses in the brain and nervous system, according to a mouse study published today in eLife.
US Army game-theory research using artificial intelligence may help treat cancer and other diseases, improve cybersecurity, deploy Soldiers and assets more efficiently and even win a poker game.
A team of scientists from EPFL has compiled environmental and epidemiological data from around the world to develop a map that shows the riskiest areas for hepatitis E outbreaks. Their work, published in Scientific Reports, opens the way to new avenues of research and prevention.
What if the missing 'environmental' factor in some of our deadliest neurological diseases were really written in our genome? Writing in Frontiers in Genetics, researchers from the University of Düsseldorf explain how viruses ended up in our DNA -- and what puts them in the frame in unsolved diseases like multiple sclerosis.
A newer form of shingles vaccine reduced outbreaks of the painful rash among patients who were transplanted with their own stem cells, according to a study led by a Duke Health researcher and published today in JAMA. The vaccine appears to offer protection from one of the most common and painful side effects of cell therapy and shows promise for patients with immune-compromising conditions.
How can a protein be a major contributor in the development of birth defects, and also hold the potential to provide symptom relief from autoimmune diseases like lupus? In a new paper published in Nature Communications, Zhu and his colleagues are helping to answer this question and uncover the mechanisms that will lead to multi-faceted prevention and treatment.
This benign virus changes as we travel, is found in two-thirds of the world's population, and has deep implications for future drug delivery and personalized medicine.